Previous 10 | Next 10 |
SYDNEY, Australia, Oct. 29, 2020 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP), a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune disease, is pleased to announce that it has entered into a Licence and Collaboration Agreement with ...
Immutep's (IMMP) has announced that its cancer therapy eftilagimod alpha (efti or IMP321) will be tested in an investigator-initiated trial against COVID-19.The Phase 2 trial will evaluate efti in up to 110 patients hospitalized with COVID-19, with primary endpoint is the patient’s cli...
Socket Mobile (SCKT) +123% on Q3 results.Dogness (DOGZ) +60% after announcing partnership with Hangzhou Huayuan Pet Products and Shanghai Chongai Trading Co. Ltd.Zedge (ZDGE) +47% on Q4 results.Solid Biosciences (SLDB) +28% on announcing collaborat...
Investigator-initiated, placebo controlled and randomized Phase II study evaluating eftilagimod alpha (“efti”) in up to 110 COVID-19 patients Immutep supplies efti to University Hospital Pilsen, Czech Republic Study tests whether the early administration of efti pr...
Encouraging clinical results from TACTI-002 and INSIGHT-004 trials of eftilagimod alpha completed recruitment for Stage 1 of Part B in TACTI-002 Study Granted United States patent relating to eftilagimod alpha and LAG525 SYDNEY, Australia, Oct. 22, 2020 (GLOBE NEWSWIRE) --...
European Patent Office has granted new patent (number 3344654) to Immutep ([[IMMP]] +9.1%) entitled “Anti-LAG-3 Antibodies” directed to Immutep’s pre-clinical product candidate, IMP761, as well as use of IMP761 in the treatment of T-cell mediated inflammato...
SYDNEY, Australia, Oct. 21, 2020 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune disease, is pleased to announce the grant of a new...
SYDNEY, Australia, Oct. 19, 2020 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune disease, is pleased to announce that interim Overa...
Nikola Corporation (NKLA) -26% after Milton resignation sends shockwaves.Eastman Kodak (KODK) -11%.Uranium Energy (UEC) -9%.Eton Pharmaceuticals (ETON) -7%.Deutsche Bank Aktiengesellschaft (DB) -7% on money laundering allegations.ING Groep N.V. (ING) -7%.Plug Power (PLUG) ...
3 Penny Stocks Gapping Up Today Are you looking for penny stocks to buy today ? If you’re like most, premarket hours are some of the most important. This is where we see stocks gapping up, gapping down, or simply beginning to see activity for the day. Not all penny stocks trade durin...
News, Short Squeeze, Breakout and More Instantly...
Media Release Study expected to enrol first participants during Q3 CY2024 SYDNEY, AUSTRALIA, July 17, 2024 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), a clinical-stage biotechnology company developing no...
2024-07-12 10:45:04 ET QuantumScape Corp (QS) QS is trading UP for the last 5 days, and it at trading at $7.84 with volume of 22,322,158 and a one day change of $0.78 (10.98%). QuantumScape Corp has a 52-week low of 4.67 and a 52-week high of $13.86. The business's 50-day moving ave...
Media Release Efti in combination with KEYTRUDA® (pembrolizumab) achieved a 35.5% response rate in evaluable patients (N=31), according to RECIST 1.1, among the highest recorded for a treatment approach not containing chemotherapy in patients with CPS <1 High complete response...